Related Experiment Video
Updated: May 17, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
The RUNX family in breast cancer: relationships with estrogen signaling
1Department of Biochemistry and Molecular Biology, Institute for Genetic Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA. chimgee@usc.edu
Abstract:
The three RUNX family members are lineage specific master regulators, which also have important, context-dependent roles in carcinogenesis as either tumor suppressors or oncogenes. Here we review evidence for such roles in breast cancer (BCa). RUNX1, the predominant RUNX family member in breast epithelial cells, has a tumor suppressor role reflected by many somatic mutations found in primary tumor biopsies. The classical tumor suppressor gene RUNX3 does not consist of such a mutation hot spot, but it too seems to inhibit BCa; it is often inactivated in human BCa tumors and its haploinsufficiency in mice leads to spontaneous BCa development. The tumor suppressor activities of RUNX1 and RUNX3 are mediated in part by antagonism of estrogen signaling, a feature recently attributed to RUNX2 as well. Paradoxically, however RUNX2, a master osteoblast regulator, has been implicated in various aspects of metastasis in general and bone metastasis in particular. Reciprocating the anti-estrogenic tumor suppressor activity of RUNX proteins, inhibition of RUNX2 by estrogens may help explain their context-dependent anti-metastatic roles. Such roles are reserved to non-osseous metastasis, because ERα is associated with increased, not decreased skeletal dissemination of BCa cells. Finally, based on diverse expression patterns in BCa subtypes, the successful use of future RUNX-based therapies will most likely require careful patient selection.
Insights
RUNX proteins act as tumor suppressors or oncogenes in breast cancer (BCa). RUNX1 and RUNX3 inhibit BCa, while RUNX2 has context-dependent roles in metastasis, requiring patient selection for therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- RUNX proteins are master regulators with context-dependent roles in cancer.
- Their involvement in breast cancer (BCa) ranges from tumor suppression to oncogenesis.
- RUNX1 is predominant in breast epithelial cells and frequently mutated in BCa.
Purpose of the Study:
- To review the evidence for RUNX family member roles in breast cancer.
- To elucidate the dual roles of RUNX proteins as tumor suppressors and oncogenes in BCa.
- To explore the implications of RUNX protein functions in BCa metastasis and therapeutic strategies.
Main Methods:
- Review of existing literature and evidence on RUNX family members in breast cancer.
- Analysis of somatic mutations in primary tumor biopsies.
- Examination of gene inactivation and haploinsufficiency studies in mouse models.
- Investigation of interactions with estrogen signaling pathways.
Main Results:
- RUNX1 and RUNX3 exhibit tumor suppressor activities in BCa, partly via antagonism of estrogen signaling.
- RUNX2, while a tumor suppressor in some contexts, is implicated in BCa metastasis, particularly bone metastasis.
- Estrogen inhibition of RUNX2 may contribute to its context-dependent anti-metastatic roles in non-osseous sites.
- Estrogen receptor alpha (ERα) is linked to increased skeletal dissemination of BCa cells.
Conclusions:
- RUNX proteins have complex, context-dependent roles in breast cancer progression and metastasis.
- RUNX1 and RUNX3 function as tumor suppressors, while RUNX2 has paradoxical roles in metastasis.
- Understanding RUNX protein functions and their interaction with estrogen signaling is crucial for BCa treatment.
- Future RUNX-based therapies will necessitate careful patient stratification based on BCa subtype and expression patterns.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
